Total Payments
$14,480
2024 Payments
$2,234
Companies
78
Transactions
1,162
Medicare Patients
3,960
Medicare Billing
$344,446
Payment Breakdown by Category
Food & Beverage$14,218 (98.2%)
Education$261.35 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,218 | 1,151 | 98.2% |
| Education | $261.35 | 11 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,255 | 144 | $0 (2024) |
| Novo Nordisk Inc | $1,234 | 128 | $0 (2024) |
| Lilly USA, LLC | $1,042 | 107 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $850.61 | 44 | $0 (2024) |
| PFIZER INC. | $820.22 | 82 | $0 (2021) |
| Amgen Inc. | $781.79 | 57 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $625.98 | 68 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $580.07 | 42 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $556.34 | 34 | $0 (2023) |
| Merck Sharp & Dohme LLC | $425.28 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,234 | 134 | ABBVIE INC. ($300.76) |
| 2023 | $1,683 | 138 | AbbVie Inc. ($271.64) |
| 2022 | $2,086 | 183 | ABBVIE INC. ($316.41) |
| 2021 | $1,573 | 110 | AbbVie Inc. ($321.00) |
| 2020 | $1,330 | 101 | Allergan, Inc. ($202.66) |
| 2019 | $1,754 | 145 | PFIZER INC. ($263.55) |
| 2018 | $1,484 | 135 | PFIZER INC. ($255.63) |
| 2017 | $2,337 | 216 | PFIZER INC. ($260.56) |
All Payment Transactions
1,162 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Obesity | ||||||
| 12/17/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Vaccines | ||||||
| 12/12/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.15 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Obesity | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: Cardiovascular | ||||||
| 11/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Obesity | ||||||
| 10/24/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.02 | General |
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 615 | 953 | $120,655 | $60,992 |
| 2022 | 18 | 878 | 1,364 | $150,897 | $76,035 |
| 2021 | 21 | 1,010 | 1,578 | $172,372 | $85,835 |
| 2020 | 26 | 1,457 | 2,460 | $259,649 | $121,584 |
Total Patients
3,960
Total Services
6,355
Medicare Billing
$344,446
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 374 | $61,594 | $27,777 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 135 | 135 | $28,080 | $16,539 | 58.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $4,500 | $3,395 | 75.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 27 | $6,045 | $2,894 | 47.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 36 | $3,420 | $2,589 | 75.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 42 | $4,778 | $2,087 | 43.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,640 | $1,733 | 65.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 55 | 130 | $3,390 | $1,152 | 34.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $1,260 | $1,058 | 84.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 66 | $2,574 | $614.94 | 23.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 14 | $1,498 | $514.93 | 34.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $455.00 | $382.07 | 84.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 36 | 38 | $326.00 | $213.85 | 65.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 19 | $95.00 | $41.80 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 421 | $69,044 | $32,139 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 129 | 129 | $26,832 | $15,994 | 59.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 42 | 42 | $11,760 | $6,763 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 91 | $10,101 | $5,221 | 51.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 72 | 73 | $4,891 | $4,661 | 95.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 22 | $4,884 | $2,426 | 49.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 72 | 73 | $2,555 | $2,032 | 79.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,640 | $1,767 | 66.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 63 | 132 | $3,828 | $1,207 | 31.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 97 | $3,783 | $999.58 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,783 | $964.60 | 34.7% |
About Dr. John Colombo, MD
Dr. John Colombo, MD is a Family Medicine healthcare provider based in Marysville, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720158579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Colombo, MD has received a total of $14,480 in payments from pharmaceutical and medical device companies, with $2,234 received in 2024. These payments were reported across 1,162 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($14,218).
As a Medicare-enrolled provider, Colombo has provided services to 3,960 Medicare beneficiaries, totaling 6,355 services with total Medicare billing of $344,446. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Marysville, MI
- Active Since 11/09/2006
- Last Updated 01/23/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720158579
Products in Payments
- VRAYLAR (Drug) $781.91
- XARELTO (Drug) $527.17
- UBRELVY (Drug) $418.19
- JARDIANCE (Drug) $413.61
- CHANTIX (Drug) $390.85
- FARXIGA (Drug) $363.74
- MOUNJARO (Drug) $330.33
- CAPLYTA (Drug) $322.56
- Trintellix (Drug) $322.10
- Victoza (Drug) $316.56
- Kerendia (Drug) $309.89
- JANUVIA (Drug) $281.33
- TRELEGY ELLIPTA (Drug) $262.64
- LYRICA (Drug) $262.34
- AJOVY (Drug) $260.30
- EVENITY (Biological) $256.14
- Aimovig (Biological) $225.39
- Ozempic (Drug) $224.79
- EMGALITY (Drug) $222.22
- Wegovy (Drug) $221.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Marysville
Dr. Delia Herzog, M.d, M.D
Family Medicine — Payments: $8,380
Family Medicine $8,380
Dr. Daniel Badenhop, M.d, M.D
Family Medicine — Payments: $8,359
Family Medicine $8,359
Dr. Jeffrey Moore, M.d, M.D
Family Medicine — Payments: $5,818
Family Medicine $5,818
Dr. Wendy Summerhill, M.d, M.D
Family Medicine — Payments: $4,265
Family Medicine $4,265
Igor Nedic, M.d, M.D
Family Medicine — Payments: $2,191
Family Medicine $2,191
Michael Shaffer, Md, MD
Family Medicine — Payments: $1,975
Family Medicine $1,975